1. Zhao J, Wu C, Qiu T, Wang Y, Li M, Wei D, Han Y, Jiang Y, Luo Y*.Establishment and validation of a nomogram for predicting the surgical difficulty of lateral retroperitoneal laparoscopic adrenalectomy.Transl Androl Urol.2023.12(1).9-18.SCI |
2. Zhao J, Wu C, Wang Y, Li M, Jiang Y, Luo Y*.Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer.Transl Cancer Res.2022.11(7).1865-1879.SCI |
3. Feng T, Wei D, Zhao J, Li Q, Guo P, Yang X, Li M, Jiang Y, Luo Y*.Construction of enzalutamide-resistant cell model of prostate cancer and preliminary screening of potential drug-resistant genes.Exp Biol Med.2021.246(15).1776-1787.SCI |
4. Feng T, Wei D, Li Q, Yang X, Han Y, Luo Y*, Jiang Y*.Four Novel Prognostic Genes Related to Prostate Cancer Identified Using Co-expression Structure Network Analysis.Front Genet.2021.12.584164.SCI |
5. Guo P#, Wang Y#, Han Y, Wei D, Zhao J, Li M, Jiang Y*, Luo Y*.Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinoma.Urol Oncol.2021.39(12).835.e19-835.e27.SCI |
6. Zhao J, Li Q, Feng B, Wei D, Han Y, Li M, Wang Y, Luo Y*, Jiang Y*.MicroRNA 149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4 2 CRPC cell line.Oncol Rep.2021.46(6).258.SCI |
7. Guo P#, Wang Y#, Han Y, Wei D, Zhao J, Li M, Jiang Y*, Luo Y*.Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis.Front Oncol.2021.11.678459.SCI |
8. Feng T#, Zhao J#, Wei D, Guo P, Yang X, Li Q, Fang Z, Wei Z, Li M, Jiang Y*, Luo Y*.Immunogenomic Analyses of the Prognostic Predictive Model for Patients With Renal Cancer.Front Immunol.2021.12.762120.SCI |
9. Luo Y*, Yang X, Basourakos SP, Zuo X, Wei D, Zhao J, Li M, Li Q, Feng T, Guo P, Jiang Y.Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway.Front Mol Biosci.2021.8.652443.SCI |
10. Luo Y*, Li Q, Yang X, Wei D, Feng B, Li M, Han Y, Zhao J, Lin Y, Li Q, Hou Z, Zhuang H, Jiang Y.Overexpression of CXCR7 is a Novel Indicator for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Patients.Dis Markers.2021.2021.6649579.SCI |
11. Luo Y*, Feng B, Wei D, Han Y, Li M, Zhao J, Lin Y, Hou Z, Jiang Y.Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.Sci Rep.2020.10(1).17674.SCI |
12. 10. Luo Y, Azad AK, Karanika S, Basourakos SP, Zuo X, Wang J, Yang L, Yang G, Korentzelos D, Yin J, Park S, Zhang P, Campbell JJ, Schall TJ, Cao G, Li L, Thompson TC*.Enzalutamide and CXCR7 inhibitor Combination Treatment Suppresses Cell Growth and Angiogenic Signaling in Castration-Resistant Prostate Cancer Models.Int J Cancer.2018.142(10).2163-2174.SCI |
13. Luo Y*, Li M, Qi H, Zhao J, Han Y, Lin Y, Hou Z, Jiang Y*.Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer.World J Surg Oncol.2018.16(1).107.SCI |
14. Luo Y*, Li MC, Zuo XM, Basourakos S, Zhang J, Yang G, Zhao JH, Han YL, Lin YH, Wang YX, Jiang YG, Lu Q, Lan L*.β-catenin nuclear translocation induced by HIF-1α overexpression leads to radioresistance of prostate cancer cells.Int J Oncol.2018.52(6).1827-1840.SCI |
15. Luo Y*, Lan L*, Jiang YG, Zhao JH, Li MC, Wei NB, Lin YH.Epithelial-mesenchymal transition and migration of prostate cancer stem cells is driven by cancer-associated fibroblasts in an HIF-1α/β-catenin-dependent pathway.Mol Cells.2013.36(2).138-144.SCI |
16. Jiang YG, Luo Y*, He DL, Li X, Zhang LL, Peng T, Li MC, Lin YH.Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.Int J Urol.2007.14(11).1034-1039.SCI |
17. Luo Y, He DL*, Ning L, Shen SL, Li L, Li X, Zhau HE, Chung LWK.Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro.BJU Int.2006.98(6).1315-1319.SCI |